tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IDXX is currently covered by 7 analysts with an average price target of $723.74. This is a potential upside of $67.01 (10.2%) from yesterday's end of day stock price of $656.73.
IDEXX Laboratories's activity chart (see below) currently has 169 price targets and 133 ratings on display. The stock rating distribution of IDXX is 50% HOLD and 50% BUY.
Analysts average stock forecasts to be materialized ratio is 89.53% with an average time for these price targets to be met of 348 days.
Highest price target for IDXX is $800, Lowest price target is $700, average price target is $760.
Most recent stock forecast was given by DAVID WESTENBERG from PIPER SANDLER on 09-Feb-2026. First documented stock forecast 24-Jun-2014.
IDEXX Laboratories is a global leader in veterinary diagnostic testing and services, as well as water quality testing solutions. The company primarily serves the companion animal veterinary market, as well as livestock and poultry producers, dairy farmers, and the biomedical research community.
IDEXX offers a wide range of diagnostic products and services, including point-of-care veterinary diagnostic products, veterinary reference laboratory diagnostic and consulting services, and practice management and diagnostic imaging systems and services for veterinarians. The company also provides health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for the biomedical research community.
In addition to veterinary diagnostic products, IDEXX also offers diagnostic and health-monitoring products for livestock, poultry, and dairy producers. These products include water testing products that test for various microbiological contaminants, as well as point-of-care electrolytes and blood gas analyzers.
During the COVID-19 pandemic, IDEXX also developed an RT-PCR test kit for human COVID-19 testing, called OPTI SARS-CoV-2 RT-PCR test kit.
IDEXX has a broad range of testing capabilities, including in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers, as well as SNAP rapid assays test kits. The company also offers veterinary software and services for independent veterinary clinics and corporate groups.
The company was founded in 1983 and is headquartered in Westbrook, Maine.
Currently out of the existing stock ratings of IDXX, 10 are a HOLD (50%), 10 are a BUY (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-Jan-2024
$750
$93.27 (14.20%)
$775
20 days ago
(09-Feb-2026)
10/12 (83.33%)
$110.21 (17.23%)
87
Buy Since 25-Jul-2024
$800
$143.27 (21.82%)
$830
26 days ago
(03-Feb-2026)
14/16 (87.5%)
$167.44 (26.47%)
147
Buy Since 29-Jan-2021
$775
$118.27 (18.01%)
$575
3 months 25 days ago
(04-Nov-2025)
8/9 (88.89%)
$52.88 (7.32%)
446
Buy Since 03-Nov-2025
$775
$118.27 (18.01%)
$540
3 months 26 days ago
(03-Nov-2025)
16/17 (94.12%)
$52.06 (7.20%)
134
Hold Since 05-May-2022
$700
$43.27 (6.59%)
$535
6 months 25 days ago
(04-Aug-2025)
8/8 (100%)
$17.22 (2.52%)
496
What is IDXX (IDEXX Laboratories) average time for price targets to be met?
Which analyst has the current highest performing score on IDXX (IDEXX Laboratories) with a proven track record?
Which analyst has the most public recommendations on IDXX (IDEXX Laboratories)?
Which analyst is the currently most bullish on IDXX (IDEXX Laboratories)?
Which analyst is the currently most reserved on IDXX (IDEXX Laboratories)?
